N-Power Medicine raised $72 Million in a Series B funding round led by Merck Global Health Innovation Fund
N-Power Medicine raised $72 Million in a Series B funding round led by Merck Global Health Innovation Fund
07/01/24, 12:03 PM
Location
redwood cityMoney raised
$72 million
Industry
therapeutics
pharmaceutical
medical
biotechnology
health care
Round Type
series b
Investors
A Us Based Healthcare Focused Investor, Merck Global Health Innovation Fund
N-Power Medicine, a clinical research and drug development platform company, has announced the initial close of its Series B funding round, with participation by a US-based healthcare focused investor. The funding round led by Merck Global Health Innovation Fund brings its total funding to date to $72 Million.
Company Info
Location
redwood city, california, united states
Additional Info
N-Power Medicine is a clinical research and drug development platform company that aims to integrate clinical research and routine care into a single workflow. Founded in 2021, it aims to boost clinical trial participation to accelerate oncology drug development. The company's platform includes The Kaleido Registry, a collection of prospective, real-time, standardized patient data designed to support clinical trials and drug development.